Antipsychotic Medication in Dementia Care: Questions for the Clinical Team
Families can feel alarmed when they see an antipsychotic medication added to a parent’s nursing-home or memory-care medication list.
Sometimes a clinician may determine that a medication is appropriate for a specific diagnosed condition or severe symptom. But antipsychotic use in older adults with dementia deserves careful, ongoing review.
The most useful family questions are: What condition or symptom is being treated? What alternatives were tried? What benefits are expected? What risks are being monitored? And when will the medication be reassessed?
Do not stop an antipsychotic abruptly without the prescribing clinician’s guidance.
Start with the exact drug and indication
Ask for:
- medication name;
- dose;
- schedule;
- start date;
- prescribing clinician;
- documented diagnosis or target symptom; and
- reason it was started.
“Behavior” is too vague.
Ask what behavior or condition the prescriber is treating.
Antipsychotics carry serious warnings in dementia
FDA-approved antipsychotic labeling includes a boxed warning about increased mortality in elderly patients with dementia-related psychosis.
Specific medicines have additional risks and indications.
One drug in the class, brexpiprazole, is FDA-approved for agitation associated with dementia due to Alzheimer’s disease, but it still carries the class boxed warning about increased mortality in elderly patients with dementia-related psychosis.
A medication being FDA-approved for one dementia-related indication does not make it appropriate for every resident with agitation.
Ask whether a new behavior was medically evaluated first
Sudden agitation or aggression can reflect:
- pain;
- infection;
- constipation;
- urinary retention;
- medication side effects;
- dehydration;
- sleep disruption;
- hunger;
- fear;
- environmental stress; or
- delirium.
Our guide When a Parent With Dementia Becomes Aggressive explains why the behavior pattern matters.
Ask what causes were evaluated before the medication was started.
Ask what non-drug interventions were tried
CMS nursing-home guidance emphasizes behavioral interventions and avoiding medications used for staff convenience.
Examples of non-drug approaches can include:
- pain treatment;
- toileting;
- reducing noise;
- changing bathing approach;
- familiar routine;
- meaningful activity;
- improving sleep;
- simpler communication;
- different seating;
- hunger or thirst relief; and
- changing the time of a difficult care task.
The correct approach depends on the resident.
Nursing-home rules require a specific clinical rationale
Federal nursing-home regulations at 42 CFR §483.45 require that psychotropic drugs be tied to a specific diagnosed condition documented in the clinical record.
They also require efforts toward gradual dose reduction and behavioral interventions unless clinically contraindicated.
For PRN psychotropic medications, federal rules include time limits and documentation requirements.
Families can ask how the facility is meeting those requirements.
Ask about gradual dose reduction
For a resident receiving a psychotropic medication, ask:
- Has a gradual dose reduction been attempted?
- If not, what clinical reason makes it contraindicated?
- What happened during prior reduction attempts?
- When will the next review occur?
- Who makes the decision?
A gradual dose reduction is a clinical process, not a family instruction to cut a pill in half.
Ask what success looks like
A medication should have a clear target.
Examples might include reducing:
- severe agitation;
- dangerous aggression;
- psychosis;
- hallucinations causing major distress; or
- another diagnosed symptom.
Ask:
“How will we know this medication is helping enough to justify the risk?”
If no one can describe the target outcome, the family has a reason to request a clinical review.
Watch for adverse effects
Depending on the medication, possible concerns can include:
- sedation;
- dizziness;
- blood-pressure changes;
- movement problems;
- swallowing problems;
- falls;
- metabolic changes; and
- other medication-specific effects.
Ask which side effects are most relevant to the exact drug.
If your parent becomes dramatically more sleepy, less mobile, or develops a new concerning symptom, contact the clinical team.
Falls and swallowing matter
Sedation, orthostatic hypotension, movement effects, or swallowing changes can increase practical care risks.
If your parent already falls frequently, ask how the medication changes the fall-prevention plan.
If swallowing is impaired, ask whether the medication or sedation could affect meal safety.
Ask about consent and communication
Families should know who has authority to make medication decisions when the resident cannot make them independently.
Ask:
- Was the resident involved?
- Was the legal representative informed when appropriate?
- What risks and benefits were discussed?
- How will the family be notified of dose changes?
- Who can request a medication review?
State law and decision-making authority vary.
Do not judge a nursing home by one antipsychotic percentage alone
CMS and Medicare publish antipsychotic-use quality data.
Those measures can be useful screening information, but a facility-level percentage does not tell you whether one specific resident’s medication is appropriate.
Use the data to ask questions rather than making an automatic conclusion.
Ask the pharmacist too
Nursing homes are required to have medication-regimen review processes.
Ask whether the consultant pharmacist has reviewed:
- indication;
- dose;
- duration;
- interactions;
- adverse effects; and
- opportunities for dose reduction.
Our broader article Medication Management in Assisted Living can help families organize medication questions across settings.
A practical example
Suppose Gerald’s nursing-home chart shows an antipsychotic started after he began striking staff during evening care.
His daughter asks what changed.
The team identifies evening pain, constipation, and a noisy shift-change period as likely contributors.
Those issues are addressed, and staff modify the evening routine.
The prescriber then reviews whether the medication is still needed and whether a gradual dose reduction is appropriate.
The family is not demanding that medication be stopped. They are asking for an individualized clinical rationale and review.
Ten questions for the clinical team
- What medication, dose, and schedule is being used?
- What diagnosed condition or specific symptom is it treating?
- What medical causes of the behavior were evaluated?
- What non-drug interventions were tried?
- What benefit should we expect?
- What adverse effects are being monitored?
- Could it affect falls, swallowing, alertness, or mobility?
- Has gradual dose reduction been attempted or considered?
- What does the consultant pharmacist recommend?
- When is the next medication review?
Sources and review date
Sources checked October 11, 2026. Medication decisions are individualized and belong with qualified prescribers. Do not start, stop, or change a psychotropic medication based on this article.
